TriSalus Life Sciences, Inc.
TLSI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $103.5M in total; no superinvestor holds it.
Other share classesTLSIW
13F holders, Q4 2023
Institutional positions in TriSalus Life Sciences, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +10 vs. Q3 2023
- Shares held
- 679.6K
- +543.0K (+397.6%) vs. Q3 2023
- Total value
- $5.74M
- +$5.04M (+721.1%) vs. Q3 2023
- New holders
- 11
- 3 more added
- Sold out
- 1
- 1 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $103.5M |
| Q1 2026 | 84 | $84.1M |
| Q4 2025 | 64 | $79.6M |
| Q3 2025 | 56 | $44.5M |
| Q2 2025 | 46 | $46.2M |
| Q1 2025 | 34 | $16.3M |
| Q4 2024 | 28 | $11.8M |
| Q3 2024 | 31 | $10.0M |
| Q2 2024 | 27 | $9.20M |
| Q1 2024 | 25 | $9.39M |
| Q4 2023 | 19 | $5.85M |
| Q3 2023 | 9 | $699.3K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding TriSalus Life Sciences, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 165,136 | $1.40M | 0.00% | +165,136 | New |
| Geode Capital Management, LLC | 125,762 | $1.06M | 0.00% | +108,523+629.5% | Added |
| HC Advisors, LLC | 101,736 | $859.7K | 0.48% | +101,736 | New |
| Connecticut Wealth Management, LLC | 57,188 | $483.2K | 0.03% | 00.0% | Unchanged |
| HRT Financial LP | 48,011 | $405.0K | 0.00% | +48,011 | New |
| Anson Capital, Inc. | 35,005 | $295.8K | 0.49% | 00.0% | Unchanged |
| Wetherby Asset Management Inc | 34,950 | $295.3K | 0.02% | +34,950 | New |
| Tyche Wealth Partners LLC | 26,664 | $225.3K | 0.05% | +26,664 | New |
| Northern Trust Corp | 18,190 | $153.7K | 0.00% | +18,190 | New |
| UBS Group AG | 16,815 | $142.1K | 0.00% | −8,117−32.6% | Reduced |
| Creative Planning | 16,216 | $137.0K | 0.00% | +16,216 | New |
| Cambridge Investment Research Advisors, Inc. | 15,554 | $131.0K | 0.00% | +15,554 | New |
| Morgan Stanley | 12,489 | $105.5K | 0.00% | +11,352+998.4% | Added |
| Tower Research Capital LLC (TRC) | 1,973 | $16.7K | 0.00% | +1,973 | New |
| Wells Fargo & Company | 1,317 | $11.1K | 0.00% | +1,316+131,600.0% | Added |
| BlackRock Inc. | 1,270 | $10.7K | 0.00% | +1,270 | New |
| Hoertkorn Richard Charles | 668 | $5.64K | 0.00% | +668 | New |
| GPS Wealth Strategies Group, LLC | 657 | $5.55K | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −415−100.0% | Sold out |